Critical considerations for successful immunotherapy trials – BioPharma Dive
|
Critical considerations for successful immunotherapy trials
BioPharma Dive More than 1,500 cancer immunotherapy drugs are in development. That number will shrink, as some will not achieve their clinical goals; and others will be withdrawn from development for strategic and/or commercial reasons. High expectations of success … |
